The US Food and Drug Administration-approved Marie system promises human-centred care, advanced technology and lower costs.
Open the following path: Computer Configuration > Windows Settings > Security Settings > Local Policies > Security Options ...
Purchasing a 20-year-old V8 Merc sports sedan may sound like a deal too good to pass up, but there are some key things you ...
During the third quarter of 2025, the company repurchased 2.0 million shares of its common stock through open market transactions for $50.0 million. At September 30, 2025, the company had $200.0 ...
SYDNEY (Reuters) -Google plans to build a large artificial intelligence data centre on Australia’s remote Indian Ocean ...
Textron Aviation has achieved a major milestone for its Cessna Citation Ascend business jet, receiving the Federal Aviation ...
Harvard astrophysicist Avi Loeb has raised concerns about interstellar comet 3I/ATLAS. He believes if the object is ...
The Chancellor of the University of Illinois announced plans to make several changes to the university’s leadership structure ...
Fujifilm marked its second consecutive year at the 2025 Global Health Exhibition in Riyadh, underscoring its long-term ...
Biohaven (BHVN) downgraded after FDA setback for VYGLXIA. Learn key risks, pipeline shifts, and what investors should watch ...
NASA's first multiple-satellite mission to another planet will map Mars' magnetic field and atmosphere in 3D, laying the ...
October 2025 marks a transformative period for biosimilars, with new FDA guidelines accelerating approvals and promising significant cost savings for health care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results